Dr. Behdad Aryavand, MD

Dr. Aryavand practices at Carient Heart & Vascular in Manassas, Virginia.

Dr. Aryavand's NPI, 1194772665, was assigned on May 28, 2006. Dr. Aryavand graduated from Ross University School of Medicine in 1995. Dr. Aryavand holds Virginia license 0101239944.

Dr. Aryavand's primary practice is Carient Heart & Vascular, at 8100 Ashton Ave, Manassas, VA 20109 in Prince William County. The practice phone is (703) 335-8750.

Dr. Aryavand's primary practice is Carient Heart & Vascular in Manassas, Virginia. Dr. Aryavand is also affiliated with UVA Health Prince William Medical Center. The medical group on file is Carient Heart & Vascular. Dmand AI also links Dr. Aryavand to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aryavand practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Aryavand's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Aryavand is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Aryavand's licenses on file in 7 states: Virginia, Florida, New York, Maryland, District of Columbia, New Jersey and Pennsylvania.

Dmand AI lists arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Aryavand treats.

CMS data shows 3,780 Medicare services from Dr. Aryavand across 26 procedure codes in 2024, for 886 Medicare patients. Medicare paid $1,133,221 for them. Every service was in an office.

CMS counts 886 Medicare patients who saw Dr. Aryavand in 2024. The largest group is 75 to 84, with 438 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aryavand's median patient age at 73, with 43% women.

In 2024, Dr. Aryavand wrote 462 Medicare Part D claims for 152 patients. 82% of them were for generic drugs. CMS names the drug for 356 of them, across 6 drugs with 11 or more claims each, at $61,767 in total drug cost. In 2023, CMS named 270 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Aryavand for performance year 2024, reported as part of a group. Dr. Aryavand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of leg revascularization (restoring blood flow) by Dr. Aryavand, more than 93% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Aryavand in 2022. The most frequent topics are Amputation, Surgical, Ischemia and Limb Salvage. Dr. Aryavand's most frequent co-authors are Homayoun A. Hashemi, MD, Dipankar Mukherjee, MD and Maseer A. Bade, MD.

CMS Open Payments shows 555 general payments to Dr. Aryavand from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 43% of the total. AngioDynamics, Inc. paid the most, $16,250.

Dr. Aryavand graduated from Ross University School of Medicine in 1995.

Dr. Aryavand is in network with 19 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.